Tupai Medical's Intraoperative Navigation 3D-4K Digital Ophthalmic Surgical Microscope Drives Innovation in Ophthalmic Procedures

The hallmark of current ophthalmic surgery is its precision and complexity. To date, ophthalmologists in China and worldwide still perform major ophthalmic procedures—such as cataract surgery, pars plana vitrectomy, and refractive surgery—manually under traditional optical microscope eyepieces. For patients with complex conditions, this conventional surgical approach poses challenges including high technical difficulty, elevated risk, prolonged intraoperative time, and slow postoperative recovery.

Tupai Medical’s flagship product, the “Intraoperative Navigation 3D-4K Digital Ophthalmic Surgical Microscope,” effectively addresses the aforementioned challenges, thereby advancing ophthalmic surgery toward digitalization and intelligence. This innovation significantly lowers the barrier to performing ophthalmic procedures, enabling more patients to receive timely surgical treatment and markedly improving prognostic outcomes.

Artery Select New Product Review, Issue 11, featuringWang Yingqi, CEO & Co-Founder of Topview Medical, andProfessor Hu Yuntao, Director of the Department of Ophthalmology, Beijing Tsinghua Changgung Hospital, Tsinghua UniversityJoin us for an in-depth look at Tuopai Medical’s “Intraoperative Navigation 3D-4K Digital Ophthalmic Surgical Microscope.”

“Intraoperative Navigation 3D-4K Digital Ophthalmic Surgical Microscope” primarily comprises two major modules: the digital 3D ophthalmic surgical microscope module and the real-time intraoperative ultra-widefield full-range swept-source OCT three-dimensional navigation module.

Digital 3D Ophthalmic Surgical Microscope Module:Surgeons are not required to operate through an eyepiece; they can perform the entire surgical procedure using large-screen 3D imaging.

Real-time Intraoperative Ultra-widefield Full-domain Swept-source OCT 3D Navigation Module:By leveraging OCT tomographic imaging and 3D modeling of planar images, three-dimensional visual information is displayed on large screens to provide physicians with real-time intraoperative 3D image navigation, significantly enhancing the accuracy and timeliness of lesion assessment.

TopSight’s “Intraoperative Navigation 3D-4K Digital Ophthalmic Surgical Microscope” is China’s first independently developed high-end digital navigation microscope, reaching an internationally leading, top-tier standard. Equipped with a 3D-4K high-definition video recording system, it allows surgeons to perform procedures comfortably in an upright position while viewing high-definition imagery. Its built-in full-range swept-source OCT provides real-time navigation, enabling precise, safe, and efficient surgical diagnosis and treatment. Synchronous focusing of the optical and digital systems facilitates seamless transitions during anterior and posterior segment surgeries, effectively addressing the performance limitations of traditional optical microscopes. The device also supports teaching modes, allowing ophthalmologists to undergo training and simulated practice for various surgical techniques during their residency.

To provide a more comprehensive understanding, Tuopai Medical’s product, the “Intraoperative Navigation 3D-4K Digital Ophthalmic Surgical Microscope,” will be launched on VCBeat Select’s New Product Review session from 19:30 to 20:30 on Thursday, May 11, 2023.

For this event, we have invitedTopEye Medical CEO and Co-founder Wang Yingqi will present the company and its products, while Professor Hu Yuntao, Director of the Department of Ophthalmology at Beijing Tsinghua Changgung Hospital, Tsinghua University, will discuss their clinical value.. We welcome everyone to scan the QR code in the poster below to register for the live stream:

Wang Yingqi

CEO & Co-founder of Topview Medical

Holds a bachelor’s and master’s degree in Biomedical Engineering from Tsinghua University; formerly served as Senior Project Engineer at PINS Medical Group. Possesses over ten years of experience in the system design, development, and team management of medical devices. Recognized as an “Outstanding Talent in the Ophthalmology Industry” by the China Association of Medical Equipment (CAME) in 2022, and designated as a Beijing “Chuying Talent.”

Hu Yuntao

Director, Department of Ophthalmology, Beijing Tsinghua Changgung Hospital, Tsinghua University

M.D., Professor, Chief Physician; Director of the Department of Ophthalmology, Beijing Tsinghua Changgung Hospital, Tsinghua University; Deputy Leader of the Ocular Trauma Group, Ophthalmology Branch, Chinese Medical Association; Vice Chairman of the Ocular Trauma Professional Committee, Ophthalmologist Branch, Chinese Medical Doctor Association; Vice Chairman of the Professional Committee on Rehabilitation for Visual Disability; Vice President of the Ophthalmology Branch, China-Japan Medical Science and Technology Exchange Association; Standing Committee Member, Ophthalmology Branch, Beijing Medical Association; Standing Committee Member, Ophthalmology Branch, Beijing Medical Doctor Association; Distinguished Expert in Retinal Stem Cell Transplantation, California Project to Cure Blindness (CPCB); Visiting Professor, USC Biomedical Therapy Institute, University of Southern California.

Topview Medical was established in October 2017, with its founding team composed of alumni from various disciplines at Tsinghua University. Headquartered in the Life Science Park in Changping District, Beijing, the company currently employs nearly 300 people. The R&D team accounts for over 40% of the workforce, and more than 70% of R&D personnel hold master’s or doctoral degrees. Topview Medical possesses industry-leading technical expertise in the fields of optoelectronics, optics, mechanics, electronics, embedded systems, software, algorithms, and AI.

Tupi Medical operates R&D centers in Beijing and Shanghai, as well as manufacturing bases in Beijing, Suzhou, and Tianjin. The company currently maintains multiple product lines, including ophthalmic optical coherence tomography (OCT) scanners, ophthalmic swept-source optical biometers, ophthalmic surgical microscopes, ophthalmic femtosecond laser surgical systems, ultra-widefield fundus cameras, and combined phacoemulsification and vitrectomy machines.

As a Chinese enterprise in the ophthalmic medical equipment industry dedicated to independent R&D and technological innovation, the company adheres to the philosophy of long-term value and upholds a democratic corporate management model centered on the spirit of scientific inquiry. Every new product and feature introduced by TopEye is designed to deliver breakthrough, advanced technical solutions to the ophthalmic healthcare sector. Committed to independent innovation, we focus on the R&D and manufacturing of high-end ophthalmic medical devices. Guided by clinical needs, we strive to collaborate with ophthalmologists to advance diagnostic and therapeutic technologies, thereby bringing greater benefits to patients with eye diseases.

Tupai has always adhered to the core values of “exploration, innovation, development, and mutual benefit,” upholding its philosophy and mission to “drive engineering advancements and new clinical discoveries in ophthalmic medicine,” and is committed to becoming a global full-platform supplier of ophthalmic medical devices.

“Artery Select New Product Showcase” is a live-streaming program under “Artery Select” dedicated to supporting the launch of innovative products by healthcare companies. The program’s mission is: to empower every milestone launch of innovative medical products.

Scan the QR code below to contact the assistant and schedule a live stream.

(If already added, please contact the assistant proactively)